News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
70,269 Results
Type
Article (1945)
Company Profile (2)
Press Release (68322)
Section
Business (21684)
Career Advice (10)
Deals (4599)
Drug Delivery (1)
Drug Development (8310)
FDA (1821)
Job Trends (822)
News (37437)
Policy (3583)
Tag
Academia (93)
Allergies (2)
Alliances (8174)
ALS (4)
Alzheimer's disease (122)
Antibody-drug conjugate (ADC) (11)
Approvals (1843)
Artificial intelligence (13)
Automation (1)
Bankruptcy (10)
Best Places to Work (606)
Biosimilars (18)
Biotechnology (5)
Bladder cancer (4)
Brain cancer (1)
Breast cancer (17)
Cancer (177)
Cardiovascular disease (4)
Career advice (10)
CAR-T (3)
Cell therapy (21)
Clinical research (7094)
Collaboration (77)
Compensation (8)
Complete response letters (2)
COVID-19 (188)
C-suite (11)
Cystic fibrosis (4)
Data (157)
Depression (1)
Diabetes (12)
Diagnostics (599)
Digital health (1)
Drug discovery (12)
Duchenne muscular dystrophy (10)
Earnings (7649)
Events (7062)
Executive appointments (41)
FDA (1935)
Featured Employer (1)
Fibrodysplasia Ossificans Progressiva (1)
Funding (49)
Gene editing (3)
Gene therapy (14)
GLP-1 (41)
Government (234)
Guidances (4)
Healthcare (1087)
IgA nephropathy (2)
Immunology and inflammation (1)
Indications (2)
Infectious disease (194)
Inflammatory bowel disease (17)
Influenza (5)
Intellectual property (11)
Interviews (1)
IPO (1632)
Job creations (245)
Job search strategy (10)
Layoffs (6)
Legal (951)
Liver cancer (16)
Lung cancer (28)
Lymphoma (10)
Manufacturing (27)
MASH (5)
Medical device (1123)
Medtech (1124)
Mergers & acquisitions (3046)
Metabolic disorders (34)
Multiple sclerosis (5)
NASH (1)
Neurodegenerative disease (6)
Neuroscience (159)
NextGen: Class of 2025 (231)
Non-profit (63)
Northern California (119)
Obesity (15)
Opinion (1)
Ovarian cancer (8)
Pain (4)
Pancreatic cancer (6)
Parkinson's disease (12)
Partnered (2)
Patents (14)
Patient recruitment (6)
People (5001)
Pharmaceutical (3)
Phase I (1938)
Phase II (2973)
Phase III (2679)
Pipeline (82)
Postmarket research (245)
Preclinical (668)
Press Release (2)
Prostate cancer (4)
Radiopharmaceuticals (23)
Rare diseases (24)
Real estate (609)
Regulatory (2590)
Reports (6)
Research institute (95)
Resumes & cover letters (1)
Schizophrenia (7)
Series A (12)
Series B (3)
Service/supplier (1)
Sickle cell disease (1)
Southern California (126)
Startups (431)
Supply chain (6)
United States (1121)
Vaccines (21)
Venture capitalists (2)
Webinars (1)
Weight loss (2)
Women's health (1)
Date
Today (18)
Last 7 days (78)
Last 30 days (247)
Last 365 days (3145)
2025 (492)
2024 (3277)
2023 (3849)
2022 (7055)
2021 (6445)
2020 (5944)
2019 (3920)
2018 (3040)
2017 (3602)
2016 (3208)
2015 (4094)
2014 (3055)
2013 (2614)
2012 (2793)
2011 (2924)
2010 (2681)
Location
Africa (93)
Alabama (1)
Arizona (7)
Asia (21312)
Australia (2432)
California (287)
Canada (204)
China (130)
Colorado (4)
Connecticut (13)
Delaware (4)
Europe (12490)
Florida (18)
Georgia (6)
Illinois (19)
India (9)
Indiana (2)
Japan (63)
Kansas (5)
Louisiana (1)
Maine (4)
Maryland (70)
Massachusetts (202)
Michigan (2)
Minnesota (26)
Missouri (3)
Nebraska (1)
Nevada (2)
New Jersey (168)
New York (129)
North Carolina (53)
Northern California (119)
Ohio (2)
Oregon (2)
Pennsylvania (46)
South America (106)
Southern California (126)
Tennessee (1)
Texas (21)
Utah (11)
Virginia (20)
Washington D.C. (2)
Washington State (10)
Wisconsin (5)
70,269 Results for "gedeon richter ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Gedeon Richter Selects Trial Interactive for Clinical Trial Management
TransPerfect Life Sciences, a leading global provider of solutions for product development and launch for the biopharmaceutical industry, announced that Gedeon Richter selected Trial Interactive’s award-winning eTMF platform and TI Collaborate eClinical solution for its upcoming clinical trials.
March 25, 2024
·
3 min read
News
AbbVie and Gedeon Richter Announce New Collaboration for the Discovery and Development of Novel Targets for Neuropsychiatric Conditions
October 24, 2024
·
10 min read
Genetown
Gedeon Richter and Sumitomo Pharma Receive Positive CHMP Opinion for RYEQO® for Treatment of Endometriosis
Gedeon Richter Plc. (‘Richter’) together with Sumitomo Pharma America, Inc. (‘SMPA’) and Sumitomo Pharma Switzerland GmbH (‘SMPS’) today announce that the Committee for Medicinal Products for Human Use (“CHMP”) of the European Medicines Agency (“EMA”) has adopted a positive opinion recommending the approval of a Type II Variation application for RYEQO®.
September 15, 2023
·
4 min read
Press Releases
Bio-Thera and Richter Execute Exclusive Commercialization Agreement for BAT2206, a Proposed Stelara® Biosimilar, for EU countries, UK, Switzerland and other selected countries
October 9, 2024
·
6 min read
Business
AbbVie and Gedeon Richter Announce Collaboration in Neuropsychiatric Diseases
AbbVie and Gedeon Richter Plc. announced a new co-development and license agreement to research, develop and commercialize novel dopamine receptor modulators for the potential treatment of neuropsychiatric diseases.
March 11, 2022
·
11 min read
Press Releases
WORK Medical Technology Group LTD Announces Strategic Partnership with Shanghai Chartwell Medical Device Co., Ltd.
March 3, 2025
·
5 min read
Biotech Bay
European Commission Approves the Commercialisation of RYEQO® for the Symptomatic Treatment of Endometriosis
Gedeon Richter Plc. together with Sumitomo Pharma America, Inc. and Sumitomo Pharma Switzerland, GmbH announce that the European Commission has granted approval of a Type II Variation application for RYEQO® for the symptomatic treatment of endometriosis in women with a history of previous medical or surgical treatment for their endometriosis.
November 2, 2023
·
4 min read
Press Releases
Boston Scientific announces agreement to acquire SoniVie Ltd.
March 4, 2025
·
7 min read
Press Releases
Kestra Medical Technologies, Ltd. Announces Closing of Upsized Initial Public Offering
March 10, 2025
·
2 min read
Press Releases
Medicus Pharma Ltd. Announces Pricing of $4.2 Million Regulation A Offering
March 7, 2025
·
5 min read
1 of 7,027
Next
